|Bid||0.0000 x 900|
|Ask||0.0000 x 1000|
|Day's range||3.6400 - 3.8400|
|52-week range||2.5200 - 16.7600|
|Beta (5Y monthly)||N/A|
|PE ratio (TTM)||N/A|
|Earnings date||15 Aug 2022|
|Forward dividend & yield||N/A (N/A)|
|1y target est||11.57|
Investor call and webcast scheduled for Monday, August 15 at 8:00 a.m. EDTRoivant will host an investor day on Wednesday, September 28 at 11:00 a.m. EDT BASEL, Switzerland and LONDON and NEW YORK and BOSTON, Aug. 03, 2022 (GLOBE NEWSWIRE) -- Roivant Sciences (Nasdaq: ROIV), a biopharmaceutical company dedicated to improving the delivery of healthcare to patients, today announced that it will host a live conference call and webcast at 8:00 a.m. EDT on Monday, August 15, 2022 to report its financi
Does the July share price for Roivant Sciences Ltd. ( NASDAQ:ROIV ) reflect what it's really worth? Today, we will...
It's been a good week for Roivant Sciences Ltd. ( NASDAQ:ROIV ) shareholders, because the company has just released its...